Nemolizumab

Tidak ditemukan merek terdaftar untuk zat aktif ini.

Tidak ada catatan makanan tercatat untuk zat aktif ini.

• AbciximabMODERAT

  Mengonsumsi Abciximab bersama Nemolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Abciximab is combined with Nemolizumab.

• AbituzumabMODERAT

  Mengonsumsi Abituzumab bersama Nemolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Abituzumab is combined with Nemolizumab.

• AbrilumabMODERAT

  Mengonsumsi Abrilumab bersama Nemolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Abrilumab is combined with Nemolizumab.

• AdalimumabMODERAT

  Mengonsumsi Adalimumab bersama Nemolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Adalimumab is combined with Nemolizumab.

• AdecatumumabMODERAT

  Mengonsumsi Adecatumumab bersama Nemolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Adecatumumab is combined with Nemolizumab.

• AducanumabMODERAT

  Mengonsumsi Aducanumab bersama Nemolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Aducanumab is combined with Nemolizumab.

• AfelimomabMODERAT

  Mengonsumsi Afelimomab bersama Nemolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Afelimomab is combined with Nemolizumab.

• AlemtuzumabMODERAT

  Mengonsumsi Alemtuzumab bersama Nemolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Nemolizumab.

• AlirocumabMODERAT

  Mengonsumsi Alirocumab bersama Nemolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Alirocumab is combined with Nemolizumab.

• AmatuximabMODERAT

  Mengonsumsi Amatuximab bersama Nemolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Amatuximab is combined with Nemolizumab.